A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer

Published:2018-12 Issue:1 Volume:15 Page:
ISSN:1542-6416
Container-title:Clinical Proteomics
language:en
Short-container-title:Clin Proteom

Author:

Enroth Stefan,Berggrund Malin,Lycke Maria,Lundberg Martin,Assarsson Erika,Olovsson Matts,Stålberg Karin,Sundfeldt Karin,Gyllensten Ulf^ORCID

Funder

Swedish Cancer Foundation (SE)acer

VINNOVA

Stiftelsen för Strategisk Forskning

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,Clinical Biochemistry,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12014-018-9216-y.pdf

Reference45 articles.

1. Ferley, GLOBOSCAN 2012: Estimated Cancer incidence, mortality and prevlance worldwide 2012. 2012.

2. Moore RG, et al. Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass. Obstet Gynecol. 2011;118(2 Pt 1):280–8.

3. Coleman RL, et al. Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses. Am J Obstet Gynecol. 2016;215(1):82e1–11.

4. Simmons AR, et al. Validation of a biomarker panel and longitudinal biomarker performance for early detection of ovarian cancer. Int J Gynecol Cancer. 2016;26(6):1070–7.

5. Boylan KLM, et al. A multiplex platform for the identification of ovarian cancer biomarkers. Clin Proteomics. 2017;14:34.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the potential of tumor‐derived DNA in urine for cancer detection: methodological challenges and opportunities;Molecular Oncology;2024-03-10

2. Discovery and preliminary validation of a new panel of personalized ovarian cancer biomarkers for individualized detection of recurrence;F1000Research;2023-11-23

3. Endometrial cancer diagnostic and prognostic algorithms based on proteomics, metabolomics, and clinical data: a systematic review;Frontiers in Oncology;2023-04-06

4. Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice;Proteomes;2023-01-10

5. Data-driven analysis of a validated risk score for ovarian cancer identifies clinically distinct patterns during follow-up and treatment;Communications Medicine;2022-10-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3